Blood routine spectroscopic isotope effect technology for tumor detection

Abstract

A blood routine spectroscopic isotope effect technology for tumor detection has the following two definitions: for one definition, a one-dimensional blood routine ultraviolet spectrogram (ordinary ultraviolet spectrum) is adopted for detection, and P53 fluorescent sequencing and carcinoembryonic antigen detection belong to the method; for the other definition, a two-dimensional ultraviolet spectrogram analysis technology provides excited-state information of interaction between DNA and protein, and provides gene expression information which cannot be obtained with a large number of one-dimensional methods. 90% of early-stage cancer is discovered through professional general surveys, and regular cancer screening is still the best way for humans to defend against cancer. By the aid of matching of one-blood-drop tumor blood routine spectroscopic isotope effect technology (two-dimensional blood routine excited-state information) with the carcinoembryonic antigen detection (one-dimensional blood routine enzyme-linked immunoabsorbent assay) technology, genetic molecule expression and electronic level expression can be screened accurately and rapidly, and great significance is provided for early diagnosis and treatment of tumors. The blood routine spectroscopic isotope technology is quite suitable for universal screening of the tumors with only one drop of blood, and the effects of early discovery and early diagnosis are realized.

Description

technical field [0001] Now the common means of cancer detection are mainly biophysical examination and histocytological examination. Biophysical examination mainly includes B-ultrasound, endoscopy, CT, MRI, X-ray, and nuclide imaging, etc. These examination methods can generally only detect tumors with a diameter of 1 to 2 cm. It takes at least 5 years or even longer for a tumor cell to multiply to such a large mass. At this time, there are about 109 cells; histocytological examination is the gold standard for tumor diagnosis, but generally after biophysical examination, specimens must be obtained through scraping, puncture or surgical biopsy. If the blood routine detection technology can be used during this period to detect the abnormal protein expressed by the tumor in the patient's blood early, early detection, early diagnosis, and early treatment can be achieved. A positive test for tumor markers does not necessarily mean a tumor, but routine blood test for tumor markers...

AI Technical Summary

Problems solved by technology

(At present, people are indeed still limited by the one-dimensional sequencing mutation of the DNA structural model, and are struggling to understand the two-dimensional space-time structure of tumors.) The traditional blood routine detection method of tumor molecular biology has encountered a cold snap